Bright Minds Biosciences Inc.
DRUG | NASDAQ
$61.14
+$1.68 (+2.83%)
Sep 22, 2026, 1:11 PM ET · Market open
Fiscal Quarter Period Ending | Q3 2026 Jun 29, 2026 | Q2 2026 Mar 30, 2026 | Q1 2026 Dec 30, 2025 | Q4 2025 Sep 29, 2025 | Q3 2025 Jun 29, 2025 | Q2 2025 Mar 30, 2025 | Q1 2025 Dec 30, 2024 | Q4 2024 Sep 29, 2024 | Q3 2024 Jun 29, 2024 | Q2 2024 Mar 30, 2024 | Q1 2024 Dec 30, 2023 | Q4 2023 Sep 29, 2023 | Q3 2023 Jun 29, 2023 | Q2 2023 Mar 30, 2023 | Q1 2023 Dec 30, 2022 | Q4 2022 Sep 29, 2022 | Q3 2022 Jun 29, 2022 | Q2 2022 Mar 30, 2022 | Q1 2022 Dec 30, 2021 | Q4 2021 Sep 29, 2021 | Q3 2021 Jun 29, 2021 | Q2 2021 Mar 30, 2021 | Q1 2021 Dec 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | -36.10 | -31.34 | -38.52 | -46.91 | -22.76 | -67.39 | -215.83 | -2.29 | -1.54 | -1.36 | -1.05 | -1.06 | -1.45 | -0.89 | -1.07 | -1.41 | -0.82 | -1.41 | -3.36 | -9.93 | -7.75 | -15.63 | -33.77 |
PEG Ratio | 0.47 | -2.03 | -0.28 | 1.05 | -1.88 | 0.01 | 2.03 | 0.01 | 0.01 | 0.02 | -0.14 | -0.21 | 0.05 | 0.05 | 0.04 | 0.11 | 0.02 | 0.19 | -0.05 | 0.44 | -0.21 | -0.21 | -0.35 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 3.18 | 3.16 | 9.31 | 7.38 | 4.85 | 4.15 | 4 | 1.28 | 1.05 | 1.47 | 1.21 | 1.24 | 1.84 | 1.26 | 1.64 | 2.41 | 1.45 | 2.09 | 3.18 | 5.52 | 2.95 | 1.84 | 19.09 |
P/FCF Ratio | -39.19 | -48.48 | -63.86 | -69.63 | -31.90 | -55.90 | -91.65 | -3.82 | -2.48 | -1.86 | -1.40 | -1.17 | -1.79 | -1.23 | -1.59 | -1.87 | -0.88 | -1.61 | -4.05 | -14.64 | -12.56 | -21.68 | -51.24 |
P/OCF Ratio | -39.19 | -48.48 | -63.86 | -69.63 | -31.90 | -55.90 | -91.65 | -3.82 | -2.48 | -1.86 | -1.40 | -1.17 | -1.79 | -1.23 | -1.59 | -1.87 | -0.88 | -1.61 | -4.05 | -14.64 | -12.56 | -21.68 | -51.24 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 121.97 | 81.48 | 57.37 | 36.10 | 86.56 | 88.27 | 126.15 | 11.32 | 35.08 | 7.69 | 8.01 | 24.26 | 11.62 | 9.83 | 21.64 | 8.11 | 22.88 | 11.72 | 31.48 | 31.38 | 68.80 | 62.90 | 22.87 |
Current Ratio | 121.97 | 81.48 | 57.37 | 36.10 | 86.56 | 88.27 | 126.15 | 11.32 | 35.08 | 7.69 | 8.01 | 24.26 | 11.62 | 9.83 | 21.64 | 8.11 | 22.88 | 11.72 | 31.48 | 31.38 | 68.80 | 62.90 | 22.87 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -2.81K | -2.78K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.80% | -3.45% | -8.47% | -4.98% | -10.12% | -5.29% | 0.09% | -13.97% | 3.77% | -10.10% | -27.92% | -23.16% | -18.88% | -22.92% | -21.30% | -28.09% | -31.52% | -41.71% | -32.55% | -14.78% | -16.14% | -6.25% | -32.42% |
Return on Assets | -0.79% | -3.41% | -8.32% | -4.84% | -9.99% | -5.22% | 0.09% | -12.67% | 3.66% | -8.79% | -24.46% | -22.21% | -17.24% | -20.53% | -20.22% | -24.50% | -30.14% | -38.15% | -31.52% | -14.31% | -15.91% | -6.15% | -31% |
Return on Invested Capital | -3.81% | -5.05% | -7.72% | -6.89% | -6.34% | -6% | -2.80% | -13.99% | 3.84% | -9.76% | -27.91% | -23.24% | -18.31% | -22.68% | -20.72% | -28.19% | -31.57% | -41.61% | -32.33% | -15.29% | -16.66% | -6.14% | -29.55% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove DRUG